期刊文献+

银屑病并发代谢异常的临床分析 被引量:5

Clinical analysis of metabolic abnormalities associated with psoriasis
下载PDF
导出
摘要 目的:分析银屑病及其4种类型并发代谢综合征(MS)和代谢异常因素的关系。方法:收集446例银屑病患者(银屑病组)和424例带状疱疹患者(对照组)的临床及实验室资料,比较两组并发MS及代谢相关因素的差异,同时比较4种类型银屑病患者间上述差异。结果:银屑病组并发MS与对照组比较结果为χ~2=12.781,P=0.000,寻常性银屑病(寻常性组)与脓疱性银屑病组(脓疱性组)并发MS的比例与对照组比较分别为χ~2=9.253,P=0.002;χ~2=13.973,P=0.000,脓疱性组中并发MS的比例与寻常性组比较为χ~2=4.426,P=0.035。银屑病组吸烟率、BP升高、三酰甘油(TG)升高、低密度脂蛋白(LDL-C)升高、高密度脂蛋白(HDL-C)降低及脂肪肝患病率与对照组比较结果分别为χ~2=17.887,P=0.000;χ~2=23.035,P=0.000;χ~2=649.269,P=0.000;χ~2=4.269,P=0.039;χ~2=67.160,P=0.000;χ~2=39.676,P=0.000;寻常性组LDL-C升高发生率与红皮病性银屑病(红皮病性组)比较为χ~2=6.323,P=0.012,与脓疱性组比较为χ~2=13.688,P=0.00,与关节病性银屑病(关节病性组)比较为χ~2=17.059,P=0.00;在空腹血糖(FBG)升高方面,脓疱性组发生率与寻常性组比较为χ~2=8.542,P=0.003;与红皮病性组比较为χ~2=3.962,P=0.047;脂肪肝患病率比较,寻常性组与红皮病性组和关节病性组比较结果分别为χ~2=8.173,P=0.004;χ~2=14.153,P=0.00,而脓疱性组与关节病性组比较结果为χ~2=4.898,P=0.027。结论:银屑病组并发MS及代谢异常明显高于对照组,脓疱性组高于其他3型。银屑病组吸烟及患脂肪肝的比例更高,BP、TG、LDLC3项指标升高及HDL-C降低概率高于对照组;寻常性组LDL-C升高概率明显高于其他3型,脓疱性组发生FBG升高概率高于寻常性组与红皮病性组;寻常性组脂肪肝患病率明显高于红皮病性组与关节病性组,而脓疱性组又明显高于关节病性组。 Objective: To analyze four types of psoriasis and its relationship with metabolic syndrome(MS) and the risk factors of abnormal metabolism. Methods: Clinical and laboratory data were compared between 446 psoriatic patients and 424 cases of her- pes zoster (as control group) regarding the occurrence of metabolic syndrome and its related factors, and the difference among the four types of psoriasis Results: Compared with the controls, the incidence of psoriasis complicated with MS was higher (X2=12.781, P=0.000), particularly in patients with vulgaris and pustular types (X2=253, P=0.002 for vulgaris; X2=13.973, P=0.000 for pustnlar psoria- sis). The incidence of pustular psoriasis complicated with MS was higher than that of psoriasis vulgaris (X2=4.426, P=0.035). There were significant differences between psoriasis and controls in the rates of smoking, high BP, elevated TG, high LDL-C, low HDL-C and the incidence of fatty liver (smoking: X2=17.887, P=0.000; high BP: X2=23.035, P=0.000; elevated TG: X2=649269, P=0.000; high LDL-C: X2=4269,P=0.039; low HDL-C: X2=67.160, P=0.000; fatty liver: X2=-39.676, P=00). The incidence of elevated LDL-C in pa- tients with psoriasis vulgaris significantly differed from that with erythrodet^nic (X2=6.323, P=0.012), pustular X2=-13.688, P=0.00) and arthritic types(X2=17.059, P=0.00); The incidence of high fast plasma glucose levels in patients with pustular psoriasis significantly dif- fered from that with either psoriasis vulgaris (X2=8.542, P=0.003) or erythrodermie psoriasis (X2=3.962, P=0.047); Complication of fatty liver in patients with psoriasis vulgaris was more often than that with erythrodermie (X2=8.173, P=0.004) or arthritic types (X2=14.153, P=0.000). Moreover, the incidence of fatty liver was different between pustular and arthritic types (X2=4.898, P=0.027). Conclusions: The incidence of MS in psoriatic patients was higher than that in the controls Patients with pustular psoriasis display the highest in- cidence of MS among the four types of psoriasis In comparison with the controls, more psoriatic patients smoke, or have fatty liver or a higher probability of having high BP, high TG, high LDL-C and low HDL-C; Patients with psoriasis vulgaris have a higher proba- bility of elevated LDL-C than that with the other three types of psoriasis The probability of high fast plasma glucose levels is higher in pustular psoriasis than in erythrodermic or vulgaris psoriasis; And the incidence of fatty liver in patients with psoriasis vulgaris is higher than that with erythrodermic and arthritic types, the latter of which exhibit low incidence of fatty liver than patients with pus- tular psoriasis.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2016年第7期507-510,共4页 Journal of Clinical Dermatology
关键词 银屑病 代谢异常 临床分析 psoriasis metabolic abnormalities clinical analysis
  • 相关文献

参考文献16

  • 1戴莎,王秀丽,宋心葵,李云龙,费璟如.银屑病患者410例合并代谢综合征分析[J].中国皮肤性病学杂志,2012,26(8):700-701. 被引量:18
  • 2李文飞,张福仁.银屑病与代谢综合征相关性研究进展[J].中国麻风皮肤病杂志,2014,30(7):409-411. 被引量:7
  • 3Davidovici BB, Sattar N, Jorg PC, et al. Psorisis and systemic inflamma-tory diseases: potential mechanistic links between skin disease and co-morbid conditions[J]. J Invest Dermatol, 2010, 130(7): 1785-1796.
  • 4Kim N, Thrash B, Menter A. Comorbidities in psoriasis patients [J]. Semin Cutan Med Surg, 2010, 29: 10-15.
  • 5Cohen AD, Shed M, Vidavsky L, et al. Association between psoriasis and the metabolic syndrome [J]. Dermatology, 2008, 216: 152-155.
  • 6AL-Mutairi N, AL-Farag S, AL-Mutairi A, et al. Comorbidities associated with psoriasis: an experience from the Middle East[J]. J Dermatol, 2010, 37(2): 146-155.
  • 7Wertheimer E,Spravehikov N,Trebicz M,et al.The regulation of skin proliferation and differerntatiation in the IR null mouse:implications for skin complications of dia-betes[J].Endocrinloloyg,2001,142(3):1234-1241.
  • 8Alsufyani MA,Golant AK,Lebwohl M.Psoriasis and the metabolic syn-drome[J].Dermatol Ther.2010,23(2):137-143.
  • 9中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3058
  • 10Augustiu M, Reich K, Glaeske G, et al. Go-morhidity and age- related prevahr+ee of psordasis; Analysis ol+ health insurance data in Germ+my[J].Aeta De,'m Venereol+ 2010+ 90(2): 147-151.

二级参考文献60

  • 1宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:611
  • 2杨松,喻荣彬,张均,孙国祥,周正元,姚才良.经济发达地区社区人群代谢综合征患病率及其主要临床症候的多样性[J].首都医科大学学报,2006,27(6):826-829. 被引量:7
  • 3Griffiths CE,Barker JN.Pathogenesis and clinical features of psoriasis[J].Lancet,2007,370(9583):263-271.
  • 4Gisondi P,Tessari G,Conti A,et al.Prevalence of metabolic syndrome in patients with psoriasis:a hospital-based case-control study[J].Br J Dermatol,2007,157(1):68-73.
  • 5Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)[J].JAMA,285(19):2486-2497.
  • 6The World Health Organization Western Pacific Region,the International Association for the Study of Obesity,and the International Obesity Task Force.The Asia-Pacific perspective:redefining obesity and its treatment[M].Melbourne:Health Communications Australia,2000.
  • 7Sommer DM,Jenisch S,Suchan M,et al.Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis[J].Arch Dermatol Res,2006,298(7):321-328.
  • 8Cohen AD,Sherf M,Vidavsky L,et al.Association between psoriasis and the metabolic syndrome.A cross-sectional study[J].Dermatology,2008,216(2):152-155.
  • 9Mallbris L,Granath F,Hamsten A,et al.Psoriasis is associated with lipid abnormalities at the onset of skin disease[J].J Am Acad Dermatol,2006,54(4):614-621.
  • 10Gu D,Reynolds K,Wu X,et al.Prevalence of the metabolic syndrome and overweight among adults in China[J].Lancet,2005,365(9468):1398-1405.

共引文献3474

同被引文献34

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部